Sydney Neuroimaging Analysis Centre
About Sydney Neuroimaging Analysis Centre
The Sydney Neuroimaging Analysis Centre (SNAC) is a state-of-the-art facility that uniquely integrates neuroimaging research with a dedicated, regulatory-compliant commercial image analysis facility. Located within the University of Sydney’s Brain and Mind Centre, SNAC utilizes cutting-edge technologies, including artificial intelligence (AI), cloud computing, and big data analytics, to provide novel insights into neurological disorders.
SNAC focuses on the development of novel biomarkers for the diagnosis and monitoring of brain diseases and offers central MRI analysis services to the pharmaceutical industry for Phase 2 and 3 clinical trials. Their AI-based software platform, iQ-Solutions, is designed for automated, workflow-integrated quantitative MRI analysis, aiming to improve radiologist productivity and enhance the detection and quantification of new brain inflammation in conditions like multiple sclerosis and dementia.
Focus Areas
Business Intelligence
| Key Investors | Australian Government (various grants), ANDHealth+, CUREator+ |
| Partnerships | University of Sydney's Brain and Mind Centre, I-MED Radiology Network, North Shore Radiology and Nuclear Medicine, Qscan Group, St Vincent's Hospital Sydney, Clene Nanomedicine, SynergyRadiology (Qualitas Healthcare Australia), The George Institute (for Trident study), MSBase, NVIDIA, GE Healthcare Australia, Royal Prince Alfred Hospital |
| Technology | Cloud-native, deep learning, computer vision, big data analytics, federated learning, Torana™ (privacy-preserving informatics platform/medical imaging gateway), integration with PACS and RIS, AI-powered MRI analysis platform |
| FDA Clearances | 1 cleared products (estimated) |
What Physicians Need to Know
For physicians, SNAC stands out by offering accelerated and highly accurate diagnostic capabilities through AI-driven automation, significantly reducing the time for brain scan analysis and improving the detection of critical conditions like acute intracranial hemorrhage. Their provision of reproducible, quantitative imaging biomarkers and volumetric analysis from MRI scans offers precise insights for diagnosing, monitoring disease progression, and guiding treatment decisions in complex neurological disorders such as MS and dementia. SNAC's solutions streamline clinical radiology workflows, reducing manual effort and enhancing productivity, while also providing access to cutting-edge research and novel biomarkers. For those involved in research, their regulatory-compliant central MRI analysis services are invaluable for clinical trials. Furthermore, SNAC offers tailored training in neuroimaging and AI technologies for medical professionals.
SNAC's AI algorithms and software platforms are designed for seamless integration with existing clinical systems. This includes direct integration with hospital Radiology Information Systems (RIS) for automated triage and reporting, and likely Picture Archiving and Communication Systems (PACS) for efficient image data exchange. Their collaborations with major imaging providers like I-MED Radiology Network also facilitate robust data flow and system compatibility. Potential integrations extend to Electronic Medical Record (EMR) systems for comprehensive patient data management and clinical trial management systems for their central image analysis services.
Reviews & Opinions
Videos
News, demos, and interviews about Sydney Neuroimaging Analysis Centre.
Videos load interactively. If none appear, search YouTube for Sydney Neuroimaging Analysis Centre →
Press & Coverage
Frequently Asked Questions
Related Companies
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]
allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]